The AHA Scientific Sessions 2022 are a gathering of scientific and clinical professionals with the aim of cardiovascular health improvement through global education.
The research undertaken by Dr Jorg Taubel et al. will be presented during the conference: First-in-Human in vivo CRISPR/Cas9 Editing of the TTR Gene by NTLA-2001 in Patients with Transthyretin Amyloidosis with Cardiomyopathy
The topics presented at the AHA Scientific Sessions 2022 are advocating scientific discovery, clinical practise and more with global speakers, sessions on digital health, leadership education for healthcare leaders and more.
To find out more AHA 2022 Registration | AHA Scientific Sessions 2022
Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.
We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.